Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Share-based Compensation (2020 - 2025)

iSpecimen has reported Share-based Compensation over the past 6 years, most recently at $1765.0 for Q4 2025.

  • Quarterly results put Share-based Compensation at $1765.0 for Q4 2025, down 83.91% from a year ago — trailing twelve months through Dec 2025 was $19836.0 (down 81.22% YoY), and the annual figure for FY2025 was $21266.0, down 91.48%.
  • Share-based Compensation for Q4 2025 was $1765.0 at iSpecimen, up from $94.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for ISPC hit a ceiling of $26.0 million in Q3 2022 and a floor of $94.0 in Q3 2025.
  • Median Share-based Compensation over the past 5 years was $22137.5 (2021), compared with a mean of $2.1 million.
  • Biggest five-year swings in Share-based Compensation: soared 229673.15% in 2022 and later tumbled 99.72% in 2023.
  • iSpecimen's Share-based Compensation stood at $11329.0 in 2021, then soared by 229673.15% to $26.0 million in 2022, then crashed by 99.58% to $108119.0 in 2023, then crashed by 89.85% to $10972.0 in 2024, then crashed by 83.91% to $1765.0 in 2025.
  • The last three reported values for Share-based Compensation were $1765.0 (Q4 2025), $94.0 (Q3 2025), and $2076.0 (Q2 2025) per Business Quant data.